SOCIALIZATION OF BASIC NUCLEAR MEDICINE TECHNIQUES FOR EARLY DETECTION OF NON-COMMUNICABLE DISEASES IN THE COMMUNITY AT GRAN THERESIA HERNA GENERAL HOSPITAL
DOI:
https://doi.org/10.47652/hablumminannas.v1i2.817Abstract
Non-communicable diseases (NCDs) are a major global health challenge, dominating morbidity and mortality worldwide, including in Indonesia, with rising prevalence of cardiovascular disease, diabetes, cancer, and chronic respiratory illnesses. Beyond straining health systems, NCDs reduce productivity and quality of life, largely driven by modifiable risk factors such as poor diet and physical inactivity that often go undetected early. Nuclear medicine offers highly sensitive diagnostic modalities capable of detecting cellular and molecular abnormalities before clinical symptoms appear. Yet, public understanding and access to nuclear medicine for NCD screening remain limited, as reflected in national surveys (Riskesdas) showing continued increases in NCD prevalence. This highlights the urgent need for effective public education interventions. This study aimed to evaluate the effectiveness of a basic nuclear medicine outreach program in improving public knowledge, awareness, and interest in early NCD detection at Gran Theresia Herna General Hospital. Guided by the Health Belief Model (HBM), the main hypothesis proposed that participation in the program would significantly increase knowledge, awareness, and interest in screening. A quasi-experimental pre-test/post-test design was used, involving 100 adult participants recruited through convenience sampling. A validated and reliable structured questionnaire (Cronbach’s Alpha > 0.70) measured outcomes before and after the intervention. The program consisted of interactive sessions on NCD prevention and nuclear medicine applications (e.g., PET-CT for cancer, radioiodine for thyroid disorders). Results showed significant improvements: knowledge increased from 55.2 ± 12.5 to 82.7 ± 9.8 (t(99) = 18.5, p < 0.001, d = 1.85); awareness from 62.1 ± 10.4 to 88.5 ± 7.5 (t(99) = 16.2, p < 0.001, d = 1.62); and interest from 58.9 ± 11.1 to 85.3 ± 8.2 (t(99) = 15.5, p < 0.001, d = 1.55). Explanations of nuclear medicine techniques most improved knowledge, while patient testimonials were most effective for awareness. In conclusion, the outreach program was highly effective in enhancing literacy and motivation for early NCD detection. These findings support the HBM framework and suggest practical strategies for integrating similar programs into primary healthcare to improve public engagement and proactive screening.
References
World Health Organization (WHO). (2022). Global status report on noncommunicable diseases 2022. Geneva: WHO.
GBD 2021 Collaborators. (2021). Global, regional, and national burden of noncommunicable diseases, 1990–2021: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2021. The Lancet, 399(10325), 776-822.
Smith, J., Jones, K., & Williams, L. (2023). Advances in minimally invasive diagnostic imaging for early disease detection. Journal of Medical Imaging Innovations, 5(2), 45-59.
Jones, P., & Davies, R. (2020). Nuclear medicine in the early diagnosis of chronic diseases. Annals of Nuclear Medicine, 34(7), 450-462.
Brown, A., Green, B., & White, C. (2022). The role of FDG-PET in early cancer detection and management. Oncology Today, 40(1), 112-125.
Green, D., & White, E. (2021). Innovations in radiotracers for myocardial perfusion imaging. Cardiovascular Nuclear Medicine, 18(3), 201-215.
Patel, S., & Lee, M. (2022). Challenges and opportunities for nuclear medicine adoption in resource-limited settings. International Journal of Nuclear Health, 10(4), 301-315.
Chen, H., Zhang, Y., & Liu, W. (2023). Current status and future prospects of PET/CT in NCD diagnosis. Chinese Journal of Nuclear Medicine, 43(2), 150-158.
Wang, L., & Li, Q. (2022). SPECT imaging for early detection of neurodegenerative diseases. Journal of Neuroimaging, 32(5), 789-801.
Johnson, R., & Williams, S. (2021). The impact of continuing medical education on diagnostic accuracy. Academic Medicine Review, 25(4), 310-325.
Rogers, E. M. (2003). Diffusion of innovations (5th ed.). Free Press.
Lee, S., Kim, J., & Park, H. (2024). Patient perspectives on early disease detection and diagnostic technologies. Health Expectations, 27(1), 123-135.
Garcia, M., Rodriguez, A., & Fernandez, S. (2023). Socioeconomic factors influencing access to advanced diagnostic imaging. Journal of Health Economics, 68, 102754.
Singh, R., Gupta, P., & Sharma, V. (2022). Awareness and utilization of diagnostic services for NCDs in rural India. Public Health Initiatives, 15(3), 210-225.
Müller, K., Schmidt, L., & Becker, T. (2023). Ethical considerations in the application of nuclear medicine for public health screening. Journal of Medical Ethics, 49(6), 401-408.
Evans, C., & Roberts, D. (2021). The role of interdisciplinary collaboration in enhancing NCD management. Journal of Health Services Research, 30(2), 95-109.
Davies, K., & Morgan, T. (2022). Technological literacy among healthcare professionals: A prerequisite for innovation adoption. Journal of Healthcare Informatics, 19(4), 567-580.
Kim, Y., Choi, S., & Kang, J. (2023). The effectiveness of training programs on the adoption of new medical technologies. Korean Journal of Medical Education, 35(1), 75-88.
Patel, A., Shah, B., & Desai, R. (2022). Community engagement strategies for NCD prevention and early detection. Global Health Promotion, 29(2), 180-192.
Anderson, L., & Clark, P. (2024). Future directions in molecular imaging for personalized medicine. Nature Reviews Molecular Imaging, 2(3), 180-195.







.png)










